Response adaptive designs for phase II trials with binary endpoint based on context-dependent information measures
From MaRDI portal
Publication:830089
DOI10.1016/j.csda.2021.107187OpenAlexW3127462840MaRDI QIDQ830089
Ksenia Kasianova, M. Ya. Kel'bert, Pavel Mozgunov
Publication date: 7 May 2021
Published in: Computational Statistics and Data Analysis (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.csda.2021.107187
experimental designinformation gainphase II clinical trialsmall population trialsweighted information
Related Items (2)
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Multi-armed bandit models for the optimal design of clinical trials: benefits and challenges
- Basic inequalities for weighted entropies
- The treatment versus experimentation dilemma in dose finding studies
- A Bayesian adaptive design for clinical trials in rare diseases
- Response‐adaptive randomization for multi‐arm clinical trials using the forward looking Gittins index rule
- Covariate-adjusted response-adaptive randomization for multi-arm clinical trials using a modified forward looking Gittins index rule
- Maximum Entropy Sampling and Optimal Bayesian Experimental Design
- An Information Theoretic Approach for Selecting Arms in Clinical Trials
- An Information Theoretic Phase I–II Design for Molecularly Targeted Agents That Does Not Require an Assumption of Monotonicity
- The Theory of Response‐Adaptive Randomization in Clinical Trials
This page was built for publication: Response adaptive designs for phase II trials with binary endpoint based on context-dependent information measures